AMOROSO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 8.938
EU - Europa 6.721
AS - Asia 6.044
SA - Sud America 601
AF - Africa 92
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.408
Nazione #
US - Stati Uniti d'America 8.710
SG - Singapore 2.252
CN - Cina 1.605
IT - Italia 1.285
RU - Federazione Russa 1.248
TR - Turchia 791
IE - Irlanda 789
UA - Ucraina 725
SE - Svezia 686
VN - Vietnam 586
GB - Regno Unito 521
BR - Brasile 503
FR - Francia 440
IN - India 409
DE - Germania 367
FI - Finlandia 182
PL - Polonia 160
CA - Canada 144
AT - Austria 75
HK - Hong Kong 74
ES - Italia 57
JP - Giappone 55
MX - Messico 53
BD - Bangladesh 43
NL - Olanda 41
PK - Pakistan 37
KR - Corea 35
BE - Belgio 34
ZA - Sudafrica 32
CZ - Repubblica Ceca 31
AR - Argentina 28
IQ - Iraq 26
LT - Lituania 26
VE - Venezuela 18
ID - Indonesia 17
CO - Colombia 15
DZ - Algeria 13
CL - Cile 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
GR - Grecia 11
IL - Israele 11
MA - Marocco 11
SA - Arabia Saudita 11
EC - Ecuador 10
KE - Kenya 10
TW - Taiwan 10
AU - Australia 8
PH - Filippine 8
PT - Portogallo 8
IR - Iran 7
PE - Perù 7
EG - Egitto 6
ET - Etiopia 6
HR - Croazia 6
JM - Giamaica 6
JO - Giordania 6
UZ - Uzbekistan 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
TT - Trinidad e Tobago 5
AL - Albania 4
BG - Bulgaria 4
CR - Costa Rica 4
KZ - Kazakistan 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
LB - Libano 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
YE - Yemen 3
AZ - Azerbaigian 2
DK - Danimarca 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
PA - Panama 2
TH - Thailandia 2
UY - Uruguay 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
Totale 22.397
Città #
Singapore 1.699
Chandler 984
San Jose 878
Jacksonville 833
Dublin 778
Ashburn 687
Dallas 680
Izmir 499
Beijing 373
Princeton 317
Southend 314
Dearborn 309
Chieti 283
Nanjing 236
The Dalles 222
Ann Arbor 207
Los Angeles 203
Wilmington 193
Ho Chi Minh City 185
Santa Clara 179
Cambridge 164
Hanoi 115
Kraków 108
Nanchang 102
Tongling 102
New York 101
Pescara 93
Woodbridge 89
Houston 87
Buffalo 82
Altamura 80
Moscow 76
Boardman 71
Munich 67
São Paulo 63
Dong Ket 62
Hong Kong 62
Council Bluffs 61
Vienna 61
Kocaeli 57
Hebei 55
Hefei 53
Kunming 49
Tianjin 46
Warsaw 46
Jiaxing 45
Helsinki 43
Redondo Beach 42
Shenyang 42
Orem 41
Teramo 41
Tokyo 41
Toronto 41
Bosa 40
Atlanta 38
Denver 37
Changsha 36
Washington 36
London 35
Montreal 35
Brussels 34
Da Nang 34
Jinan 34
Ottawa 34
Milan 33
Brooklyn 32
Chennai 32
Chicago 31
Rome 31
Norwalk 30
Stockholm 27
Brno 26
Poplar 26
Ningbo 24
Hangzhou 23
Nuremberg 23
Amsterdam 22
Augusta 22
Frankfurt am Main 22
Seoul 22
Bologna 21
Haiphong 21
Rio de Janeiro 21
Turku 21
Johannesburg 20
Guangzhou 19
Phoenix 19
Seattle 18
Ankara 16
Boston 15
Mexico City 15
Orange 15
Auburn Hills 14
Hải Dương 14
Mumbai 14
San Francisco 14
San Mateo 14
San Vito Chietino 14
Shanghai 14
Biên Hòa 13
Totale 13.498
Nome #
1,3-Asymmetric induction: Highly enantioselective synthesis of α-amino acids via 2,5-trans disubstituted imidazolidin-4-ones 1.230
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 250
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 189
Anticancer Activity of Stilbene-Based Derivatives 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 187
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 186
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 182
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells 182
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 176
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 176
Sintesi di nuovi derivati dell'anello 2-ossazolidinonico: molecole di notevole interesse come ausiliari chirali e come potenziali agenti antimicrobici 174
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 173
Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes 170
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 168
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 168
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 166
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 165
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 164
2-Substituted Benzothiazoles as Antiproliferative Agents: Novel Insights on Structure-Activity Relationships 163
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 161
Recent developments of amidine-like compounds as selective NOS inhibitors 160
Antilipemic agents: synthesis and chemical separation of chiral analogues of gemfibrozil 159
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 158
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 158
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 156
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 155
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 155
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 154
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 154
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 153
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 153
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 153
Asymmetric synthesis of enantiomerically enriched chiral fibrates, thiols and aminoacids 152
Direct resolution of α-monoalkyl-α-aryloxyacetic acids via ester or imide derivatives 151
Synthesis and antiplatelet activity of gemfibrozil chiral analogues 151
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 149
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 148
Synthesis of diastereomerically enriched 2-bromoesters and their reaction with nucleophiles 148
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer 148
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 148
Chiral analogues of clofibrate: dynamic kinetic resolution via 2-bromoimides 146
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 146
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 146
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 145
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 145
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 144
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 143
4-Substituted prolines, useful reagents in enantioselective synthesis and conformational restraints in bioactive peptidomimetics design 142
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 142
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 140
Antiplatelet activity of gemfibrozil chiral analogues 140
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 140
Synthesis and antiplatelet activity of clofibric acid analogues 139
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 139
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 136
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 136
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 136
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 135
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 134
Synthesis of chiral a-substituted β-amino acids starting from 6-alkylperihydropyrimidin-4-ones 132
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 132
Optically active 2-substituted carboxylic acids isosters of fibrates by 2-bromo esters 131
The anticancer potential of Peroxisome Proliferator-Activated Receptor antagonists 131
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 130
Amidine-Based Compounds Affecting L-Arginine Metabolism 130
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 129
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 129
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 128
null 128
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 128
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 127
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 127
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 126
Structural development studies of PPARs ligands based on tyrosine scaffold 126
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 126
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 124
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 124
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 123
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 123
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 123
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 123
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 122
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 122
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 120
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 120
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 119
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 119
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 119
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 118
Isosteres of chiral clofibric acid analogs: synthesis, resolution, absolute configuration and HPLC detection of the optical purity 117
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 117
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
Candida cylindracea lipase-mediated kinetic resolution of alpha-substituted alpha-aryloxyacetic acid methyl esters 116
Asma e broncopneumopatia cronica ostruttiva 116
Totale 15.544
Categoria #
all - tutte 79.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 0 0 0 0 188 16 132
2021/2022976 23 14 31 148 108 26 37 80 122 38 113 236
2022/20232.795 208 368 190 297 263 548 146 226 356 33 90 70
2023/20241.296 101 46 110 38 80 401 297 28 7 45 15 128
2024/20253.300 143 626 516 76 57 143 196 171 288 166 443 475
2025/20267.467 557 287 960 923 739 417 1.242 494 1.390 458 0 0
Totale 23.331